Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

SAGA Diagnostics

Saga logo

 

SAGA Diagnostics AB is a cancer diagnostics and disease monitoring company with focus on companion diagnostics for tissue biopsies and “liquid biopsies” such as blood samples. The company offers laboratory services to the pharmaceutical industry, healthcare, and academia.

The methods used by SAGA Diagnostics allow detection and analysis of circulating tumor DNA in the bloodstream and other “liquid biopsies” with exceptional sensitivity. A regular blood sample reveals not only the presence of cancer but also the quantity of tumor-specific gene mutations that can help guide therapy and detect metastatic cancer earlier. 

Dr Lao Saal and Anthony George founded SAGA Diagnostics based on on leading research from Department of Clinical Sciences at Lund University.

SAGA Diagnostics' website
 

 

 

SAGA Diagnostics

A cancer diagnostics and disease monitoring company with focus on companion diagnostics for tissue biopsies and “liquid biopsies”. 

Founded by Lao Saal and Anthony George.

Portfolio company since 2016.

 

Portfolio Manager LU Holding:

christine [dot] widstrand [at] innovation [dot] lu [dot] se (Christine Widstrand), phone +46 70 928 63 78